Public Outcry Prompts Novartis To Cancel Vasella Non-Compete Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis drops plan to pay outgoing chairman Daniel Vasella $78 million to stop him working for competitors, bowing to growing concerns in Switzerland over executive compensation.